Trending News

State Department Issues New, Immediate Requirement for Nonimmigrant Visa Applicants

Adjudicating Nonimmigrant Visa Applicants in Their Country of Residence — Implications for Employers and Employees

District Court Rejects First Amendment Challenge to California Climate Disclosure Requirements

This Week in 340B: August 5 – 11, 2025

DOL Resurrects PAID Program to Supervise Employers’ Self-Audits and Settlements of Potential FLSA and FMLA Violations

Trump Administration Issues AI Action Plan and AI Executive Orders

Winning the Race: America’s AI Action Plan

Innovation Over Regulation – Trump Unveils America’s AI Action Plan

Caught in the Act: Practical and Legal Considerations When Executives’ Office Love Affair Exposed

Florida’s CHOICE Act Becomes Law, Enhancing Certain Non-Compete Agreements

GlobeNewswire Biotech

Website

www.globenewswire.com

Featured Biotech Press Releases From GlobeNewswire

UAE Approves BioAro’s Longevity+ Supplement, Signaling Major Market Potential in Global Preventive Health
Posted On Tuesday, July 08, 2025
Ascentage Pharma Appoints Dr. Veet Misra as Chief Financial Officer and Eric Huang as Senior Vice President of Global Corporate Development and Finance
Posted On Monday, July 07, 2025
Luma Nutrition Magnesium Glycinate Surpasses 10,000 Monthly Sales on Amazon
Posted On Monday, July 07, 2025
Generation Bio Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)
Posted On Monday, July 07, 2025
Vincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to Stockholders
Posted On Monday, July 07, 2025
Ascendis to Share Its Latest Endocrinology Rare Disease Data at ENDO 2025
Posted On Monday, July 07, 2025
The American Society of Pain and Neuroscience (ASPN) Publishes Consensus Guidelines for the Use of 60-Day Peripheral Nerve Stimulation (PNS) Therapy, Highlighting Strong Clinical Applications for SPR® SPRINT® PNS
Posted On Monday, July 07, 2025
Synfini Adds $8.9 Million Discovery Funding to Speed Small Molecule Drug Development
Posted On Monday, July 07, 2025
SELLAS Life Sciences Appoints Linghua Wang, MD, PhD, to Scientific Advisory Board
Posted On Monday, July 07, 2025
Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-101 (IL13Ra2-targeted CAR T-cells) to Treat Astrocytomas and Glioblastoma
Posted On Monday, July 07, 2025
Conduit Pharmaceuticals Files New Patents Following AI-Driven Combination Discoveries
Posted On Monday, July 07, 2025
Denali Therapeutics Announces FDA Acceptance and Priority Review of Biologics License Application (BLA) for Tividenofusp Alfa for Hunter Syndrome (MPS II)
Posted On Monday, July 07, 2025
KALA BIO to Host Virtual Key Opinion Leader (KOL) Event to Discuss the Potential of KPI-012 for the Treatment of Persistent Corneal Epithelial Defect (PCED)
Posted On Monday, July 07, 2025
UroGen Announces Completion of Enrollment in the Phase 3 UTOPIA Clinical Trial of UGN-103 for the Treatment of Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer
Posted On Monday, July 07, 2025
Collegium Announces $150 Million Share Repurchase Program
Posted On Monday, July 07, 2025
Artelo Biosciences Announces Positive Preclinical Efficacy with ART12.11 in Stress-Induced Depression Model
Posted On Monday, July 07, 2025
Jasper Therapeutics Reports Clinical Data Update from Briquilimab Studies in Chronic Spontaneous Urticaria
Posted On Monday, July 07, 2025
Onco360 Has Been Selected as a National Specialty Pharmacy for Augtyro™ (repotrectinib)
Posted On Monday, July 07, 2025
Cogent Biosciences Announces Positive Top-line Results Achieving Statistical Significance Across All Primary and Key Secondary Endpoints from the SUMMIT Trial of Bezuclastinib in Patients with Non-Advanced Systemic Mastocytosis
Posted On Monday, July 07, 2025
Genelux Corporation Announces Appointment of Eric Groen as General Counsel, Corporate Secretary, Chief Compliance Officer and Head of Business Development
Posted On Monday, July 07, 2025
BioCryst Appoints Babar Ghias Chief Financial Officer and Head of Corporate Development
Posted On Monday, July 07, 2025
OMass Therapeutics to Present New Preclinical Data For its Best-in-Class MC2 Program at ENDO 2025
Posted On Monday, July 07, 2025
Orchard Therapeutics Announces Last Patient Treated in Registrational Trial of OTL-203 for MPS-I Hurler Syndrome
Posted On Monday, July 07, 2025
Abinopharm, Inc. and EGT Synbio Announce Successful Human Clinical Trials on Oral L-Ergothioneine (Dr.Ergo®) for Skin Health
Posted On Sunday, July 06, 2025
Apogee Therapeutics to Host Conference Call to Report Part A 16-Week Data from the Phase 2 APEX Trial of APG777 in Patients with Moderate-to-Severe Atopic Dermatitis on July 7, 2025
Posted On Sunday, July 06, 2025

Print